Maker of weight loss drug Wegovy gets calls from 'scared' food bosses

Novo chief executive Lars Fruergaard Jorgensen says food giants are 'scared' about how quickly weight-loss drugs will be rolled out.

Makers of everything from snack food to knee implants are facing a potential threat from Novo Nordisk's powerful appetite-suppressing treatments. So they’re calling the drugmaker for advice.

“A couple of CEOs from, say, food companies have been calling me,” Novo chief executive Lars Fruergaard Jorgensen said during a wide-ranging discussion. He declined to name names, saying questions had centred on how the drugs work and how fast they would roll out. “They are scared about it,” he said.